GP
GSK plc Portfolio holdings
AUM
$599M
This Fund
S&P 500
1 Year Est. Return
–
AUM
$599M
AUM Growth
-$200M
(-25%)
Holding
15
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CRISPR Therapeutics
CRSP
$5.4B
| $153M | 25.57% |
3,220,627
|
|
||
2
Wave Life Sciences
WVE
$1.27B
| $132M | 22.08% |
18,245,691
|
|
||
3
BioNTech
BNTX
$24.5B
| $79.1M | 13.2% |
889,824
|
|
||
4
Vir Biotechnology
VIR
$1.65B
| $76.6M | 12.79% |
8,550,954
|
|
||
5
IDEAYA Biosciences
IDYA
$2.59B
| $44.4M | 7.41% |
1,333,333
|
|
||
6
Lyell Immunopharma
LYEL
$405M
| $30.3M | 5.06% |
1,512,659
|
|
||
7
Cytokinetics
CYTK
$10.4B
| $22.4M | 3.75% |
340,434
|
|
||
8
Spero Therapeutics
SPRO
$159M
| $21.5M | 3.59% |
9,190,606
|
|
||
9
Fulcrum Therapeutics
FULC
$463M
| $13.7M | 2.29% |
1,785,714
|
|
||
10
CVRx
CVRX
$148M
| $9.53M | 1.59% |
1,007,583
|
|
||
|
BCYC
11
Bicycle Therapeutics
BCYC
$325M
| $7.1M | 1.18% |
1,529,561
|
|
||
12
Nkarta
NKTX
$230M
| $6.65M | 1.11% |
3,150,732
|
|
||
13
Regenxbio
RGNX
$356M
| $2.27M | 0.38% |
271,456
|
|
||
14
Harvard Bioscience
HBIO
$26.5M
| – | – |
-1,115
|
|
||
15
Senseonics Holdings Inc
SENS
$348M
| – | – |
-10,856
|
|